Indivior logo

INDV - Indivior News Story

156.4p 3.4  2.2%

Last Trade - 10:10am

Market Cap £1.12bn
Enterprise Value £646.5m
Revenue £485.4m
Position in Universe 407th / 1819

Indivior PLC - Notice of Results

Mon 20th April, 2020 7:00am
RNS Number : 1039K
Indivior PLC
20 April 2020


Indivior to Announce First Quarter 2020 Results on May 14th and Host Conference Call


Slough, UK, and Richmond, VA, 20 April 2020 - Indivior PLC (LON: INDV) today announced that it will release its first quarter 2020 results on May 14th at 12:00 p.m. London time (7:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at


Key members of Indivior's leadership team led by Shaun Thaxter, Chief Executive Officer, will host a conference call to discuss the results and address questions from qualified analysts and investors at 1:00 p.m. London time (8:00 a.m. U.S. Eastern).


Access the Live Webcast / Call for the Results on May 14th

The live webcast event will be available on the "Investors" section of the company's website at The webcast link is Participants also may access the results presentation telephonically: US participants 1-631-510-7495; international participants +44 (0) 2071 928000. Please reference confirmation number 9439336. A replay of the presentation will be available at


About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease.


Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 800 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit to learn more. Connect with Indivior on LinkedIn by visiting



Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.